Trial Profile
Aripiprazole in Children and Adolescents With Bipolar Disorder and ADHD: A Randomized Double Blind Placebo Controlled Trial
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Aug 2009
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary)
- Indications Attention-deficit hyperactivity disorder; Bipolar disorders; Bipolar I disorders; Bipolar II disorders
- Focus Therapeutic Use
- 06 Aug 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov
- 23 Nov 2005 New trial record.